NDC 0378-6961-32 - Glatiramer Acetate
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0378-6961
- Requested NDC
- 0378-6961-32
- Package NDCs from labels
- 0378-6961-32, 0378-6961-12
- Manufacturer
- Mylan Pharmaceuticals Inc.
- Effective date
- 2025-02-07
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Glatiramer Acetate - Mylan Pharmaceuticals Inc. | Mylan Pharmaceuticals Inc. | 2025-02-07 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0378-6961-12 | Glatiramer Acetate | 12 in 1 CARTON | INJECTION, SOLUTION | 12 | 14 | |
| 0378-6961-32 | Glatiramer Acetate | 1 in 1 BLISTER PACK | INJECTION, SOLUTION | 1 | 14 | |
| 0378-6961-32 | Glatiramer Acetate | 1 mL in 1 SYRINGE | INJECTION, SOLUTION | 1 | 14 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0378-6961-12 | ML - Milliliter | 0378-6961 | f5c8bb2f-60fd-4b4e-a42d-09ecb96fd24e | 1 | 2017-11-06 |
| 0378-6961-32 | ML - Milliliter | 0378-6961 | cfd8ac14-f76a-46a9-b1fd-e114a0782fa7 | 1 | 2017-11-06 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Glatiramer Acetate | GLATIRAMER ACETATE | AJENAT PHARMACEUTICALS LLC | 1ec10223-880d-402f-a759-9cd179bf09de | 2026-09-10 | Boxed warning, Warnings, Adverse reactions | 1487361 5M691HL4BO |
| GLATIRAMER ACETATE | GLATIRAMER ACETATE | Zydus Pharmaceuticals USA Inc. | 0aa4ff2a-ce8e-46cd-830f-a264cc582be2 | 2026-08-19 | Boxed warning, Warnings, Adverse reactions | 1487361 5M691HL4BO |
| Glatopa | GLATIRAMER ACETATE | Sandoz Inc | 5f01e40a-b6f6-40fb-b37c-3d06f1428e86 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | 1487361 5M691HL4BO |
| Copaxone | GLATIRAMER ACETATE | Teva Neuroscience, Inc. | aa88f583-4f5f-433b-80b4-1f4c9fb28357 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | 1487361 5M691HL4BO |
| Mannitol | MANNITOL | Hospira, Inc. | 8ad3145e-00e7-4412-b9a5-06f00f264f30 | 2026-04-21 | Warnings, Adverse reactions | 3OWL53L36A |
| Glatiramer Acetate | GLATIRAMER ACETATE INJECTION | UPSHER-SMITH LABORATORIES, LLC | 707a64ef-964e-44a3-8a0f-fcc2eb5b1af2 | 2026-01-15 | Boxed warning, Warnings, Adverse reactions | 1487361 5M691HL4BO |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 8f8f53e3-fe31-e7b5-e053-2995a90a710d | 2025-11-14 | Warnings | 3OWL53L36A |
| QR PAIN | ANALGESIC | MARYHELENE ENTERPRISES INC | 9984a510-30be-4013-e053-2995a90a841e | 2025-11-14 | Warnings | 3OWL53L36A |
| Mannitol | MANNITOL | ProPharma Distribution | 430669d7-9ad1-9a04-e063-6394a90ababb | 2025-11-07 | Warnings, Adverse reactions | 3OWL53L36A |
| GLATIRAMER ACETATE | GLATIRAMER ACETATE | Italfarmaco SpA | 1b3a60de-2191-4b15-be69-01329da87711 | 2025-10-31 | 1487361 5M691HL4BO | |
| Sorbitol-Mannitol | SORBITOL AND MANNITOL | ICU Medical Inc. | 5b44e248-4b7b-4777-954a-921c7b309944 | 2025-10-30 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | ICU Medical Inc. | ba7bf864-8a4d-4262-8fd1-00174fa2f9d1 | 2025-10-24 | Warnings, Adverse reactions | 3OWL53L36A |
| Osmitrol | MANNITOL | Baxter Healthcare Company | 0d914965-7001-45cb-ba51-d7c5964b05bc | 2025-08-26 | Warnings, Adverse reactions | 3OWL53L36A |
| Mannitol | MANNITOL | Henry Schein, Inc. | e2444db1-9dfe-451f-a33c-9b00786464d2 | 2025-05-20 | Warnings, Adverse reactions | 3OWL53L36A |
| Glatopa | GLATIRAMER ACETATE | Bryant Ranch Prepack | 0679689e-8930-4d6a-b922-5125082b2716 | 2025-03-27 | Warnings, Adverse reactions | 5M691HL4BO |
| Glatopa | GLATIRAMER ACETATE | Bryant Ranch Prepack | 028fdf0e-2340-407b-bcd8-5a99accdddbf | 2025-03-27 | Warnings, Adverse reactions | 1487361 5M691HL4BO |
| Glatiramer Acetate | GLATIRAMER ACETATE | Sun Pharmaceutical Industries, Inc. | f90cc5f5-56a1-48dc-a4fc-0ae89ef61deb | 2025-02-20 | Boxed warning, Warnings, Adverse reactions | 5M691HL4BO |
| Glatiramer Acetate | GLATIRAMER ACETATE | Sun Pharmaceutical Industries, Inc. | dfacc3e2-5c91-41de-a377-873276a5cf67 | 2025-02-18 | Boxed warning, Warnings, Adverse reactions | 1487361 5M691HL4BO |
| Glatiramer Acetate | GLATIRAMER ACETATE | Mylan Pharmaceuticals Inc. | f38b5606-d2d7-44ec-912f-46882aa2fa7b | 2025-02-07 | Boxed warning, Warnings, Adverse reactions | 5M691HL4BO |
| Glatiramer Acetate | GLATIRAMER | Mylan Pharmaceuticals Inc. | 456a34c7-8511-4000-99a7-ad8f8de6d35e | 2025-02-07 | Boxed warning, Warnings, Adverse reactions | ANDA206936 0378-6961-12 0378-6961-32 0378-6961 00378696132 1487361 f5070abd-2219-47fa-8ff2-c0b147ea3eb7 456a34c7-8511-4000-99a7-ad8f8de6d35e 5M691HL4BO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.